Spyre Therapeutics, Inc. - Common Stock, $0.0001 par value (SYRE)

CUSIP: 00773J202

Q3 2024 13F Holders as of 30 Sep 2024

Holder snapshot 7 signals
Share change
+732,563
Put/Call ratio
217%
SEC-reported price per share
$29.41
Number of holders
118
Value change
+$36,820,905
Number of buys
70
Open additional details 1 more signal available
Number of sells
42
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
101,961,572

Security key

00773J202

Report period

Q3 2024

Institutions

118

Top holders

10

Ownership snapshot

Top reported holders of SYRE - Spyre Therapeutics, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
0/15
Latest evidence
30 Jun 2024
13F Highest disclosed value: $176,512,680 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

FMR LLC has the largest disclosed position value at $176.51M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.
Disclosed position value Top 5
FMR LLC $176.51M
Fairmount Funds Management LLC $94.47M
RTW INVESTMENTS, LP $76.6M
PERCEPTIVE ADVISORS LLC $71.26M
Venrock Adviser, LLC $63.13M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
FMR LLC
13F
Company
13F
—
denominator unverified
$176,512,680
7,507,983 shares
— 30 Jun 2024
Fairmount Funds Management LLC
13F
Company
13F
—
denominator unverified
$94,465,555
4,018,101 shares
— 30 Jun 2024
RTW INVESTMENTS, LP
13F
Company
13F
—
denominator unverified
$76,604,044
3,258,360 shares
— 30 Jun 2024
PERCEPTIVE ADVISORS LLC
13F
Company
13F
—
denominator unverified
$71,259,233
3,031,018 shares
— 30 Jun 2024
Venrock Adviser, LLC
13F
Company
13F
—
denominator unverified
$63,134,882
2,685,448 shares
— 30 Jun 2024
BRAIDWELL LP
13F
Company
13F
—
denominator unverified
$59,116,788
2,514,538 shares
— 30 Jun 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
118
Shares
51,375,323
Rows available
118
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders
106
Q3 2024 holders
118
Holder diff
12
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 value Q3 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .